Abiopharma

🔍 Fogarty Elizabeth (Executive)

Company: GXO Logistics, Inc. (GXO)

Report Date: 2026-04-01

Detailed Transactions and Holdings:

• Acquired 937 shares of Common Stock (Direct)
  Date: 2026-04-01 | Code: M | equity_swap_involved: 0 | shares_owned_after: 16,364.00 | transaction_form_type: 4
• Sold 435 shares of Common Stock at $51.85 per share (Direct)
  Date: 2026-04-01 | Code: F | equity_swap_involved: 0 | shares_owned_after: 15,929.00 | transaction_form_type: 4 | Footnotes: F1, F1
• Sold 937 shares of Restricted Stock Units (Derivative)
  Date: 2026-04-01 | Code: M | equity_swap_involved: 0 | transaction_form_type: 4 | Footnotes: F2, F3, F3

Footnotes:

• F1: No shares were sold by the Reporting Person. These shares were withheld by GXO Logistics, Inc. ("GXO") to fund tax liability attributable to the vesting and settlement of the Restricted Stock Units ("RSUs") reported on this Form 4. These RSUs vested and were settled on April 1, 2026, as originally scheduled, and there were no related discretionary transactions or open market sales.
• F2: Each RSU represents a contingent right to receive, either (i) one share of GXO common stock, par value $0.01 per share ("GXO Common Stock"), or (ii) a cash payment equal to the fair market value of one share of GXO Common Stock.
• F3: These RSUs vested in four equal annual installments on April 1, 2023, April 1, 2024, April 1, 2025, and April 1, 2026, subject to the Reporting Person's continued employment with the Issuer.